Research Notes

Fly Model of Parkinson's Disease With genome projects finishing at an ever quickening pace, many new animal models of human disease are being developed. A very promising one is a Drosophila version of Parkinson's disease (M.B. Feany and W.B. Bender, "A Drosophila model of Parkinson's disease," Nature, 404:394-8, March 23, 2000). At Harvard Medical School, Mel Feany, an instructor in pathology, and Welcome Bender, a professor of biological chemistry and molecular pharmacology, created flies trans

Written byRicki Lewis
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Fly Model of Parkinson's Disease

With genome projects finishing at an ever quickening pace, many new animal models of human disease are being developed. A very promising one is a Drosophila version of Parkinson's disease (M.B. Feany and W.B. Bender, "A Drosophila model of Parkinson's disease," Nature, 404:394-8, March 23, 2000). At Harvard Medical School, Mel Feany, an instructor in pathology, and Welcome Bender, a professor of biological chemistry and molecular pharmacology, created flies transgenic for the human gene encoding alpha synuclein. The flies show the dense brain inclusions called Lewy bodies characteristic of the human diseased brain, the telltale depletion of dopaminergic neurons, and motor symptoms--they cannot climb the walls of their vials, as flies tend to do. As in humans, the impairment begins gradually in midlife and worsens with age. Lifespan appears normal, if the animals are properly cared for. "These flies sit down on their food, where ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies